Cas:54018-17-6 Carboxymethylcellulose sodium salt manufacturer & supplier

Chemical Name:Carboxymethylcellulose sodium salt

CAS.NO:54018-17-6

Synonyms:Ethanoic Acid;2,3,4,5,6-Pentahydroxyhexanal;Carboxymethyl Cellulose;Carboxymethylcellulose

Molecular Formula:C₈H₁₆NaO₈

Molecular Weight:263.2

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Ethanoic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Carboxymethylcellulose physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3,4,5,6-Pentahydroxyhexanal Use and application,Ethanoic Acid technical grade,usp/ep/jp grade.

Related News: In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers. Carboxymethylcellulose sodium salt manufacturer At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. Carboxymethylcellulose sodium salt supplier Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as bulk pharmaceutical chemicals (BPCs). Carboxymethylcellulose sodium salt vendor In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers. Carboxymethylcellulose sodium salt factory At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.